SOCS3 and optic nerve regeneration
SOCS3 和视神经再生
基本信息
- 批准号:8258717
- 负责人:
- 金额:$ 43.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAxonCircadian RhythmsCytokine Inducible SH2-Containing ProteinDataDiseaseEye diseasesFailureFoundationsGenesGlaucomaHealthInheritedKnock-outKnockout MiceKnowledgeLeadLightMediatingMediator of activation proteinModelingMolecular TargetMusNatural regenerationNeuronsNeuropathyOptic NerveOptic Nerve InjuriesOpticsPTEN genePathway interactionsPatientsPilot ProjectsProtein Tyrosine PhosphataseRecovery of FunctionResearchRetinalRetinal Ganglion CellsSTAT3 geneSideSignal PathwaySignal TransductionSirolimusSiteSynapsesTSC1 geneTherapeuticTransgenic MiceTranslatingaxon growthaxon regenerationgain of functionhuman FRAP1 proteininhibitor/antagonistinjuredinsightloss of functionmTOR Inhibitormouse modelmutantneurodevelopmentneuronal survivalnovel therapeuticsoptic nerve regenerationregenerativerepairedresearch studysrc Homology Region 2 Domainsuprachiasmatic nucleus
项目摘要
DESCRIPTION (provided by applicant): Optic nerve damage and regeneration failure are major features of glaucoma, inherited and traumatic optic neuropathies, and other blinding diseases. Developing strategies to promote anatomical regeneration and functional re-connection of injured optic nerve has been a long-standing challenge. By using an intraorbital optic nerve injury model in adult mice, we discovered that conditional deletion of SOCS3 and PTEN/TSC1 in RGCs promotes significant neuronal survival and axon regeneration. Our further studies suggested mTOR as a critical mediator of axon regeneration after PTEN/TSC1 deletion, likely by controlling the ability of injured neurons to synthesize materials for axon growth. On the other side, our data suggested that axon regeneration after SOCS3 deletion depends on gp130 signaling. In this proposal, we will address the following questions: First, what is the effector of SOCS deletion in promoting neuronal survival and axon regeneration and whether SOCS3 is the only key negative regulator? Second, do SOCS3-dependent and PTEN/TSC1-dependent pathways interact? Third, are regenerating axons able to find their pathway and mediate functional recovery? We expect that these experiments will provide important insights into the understanding the mechanisms of optic axon regeneration and the development of neural repair therapeutics.
PUBLIC HEALTH RELEVANCE: Optic nerve damage and regeneration failure are major features of glaucoma, inherited and traumatic optic neuropathies, and other blinding diseases. Developing strategies to promote anatomical regeneration and functional re-connection of injured optic nerve has been a long-standing challenge. By AAV-Cre-assisted conditional knockout of floxed mouse genes, we recently made an exciting discovery that deletion of SOCS3 (suppressor of cytokine signaling 3) in adult retinal ganglion cells (RGCs) enables robust long-distance axon regeneration after intraorbital optic nerve injuries, revealing a potentially important signaling pathway in regulating axon regenerative ability of mature CNS neurons. The objectives of this proposed study are two-folds: to determine the underlying mechanisms permitting axon regeneration in SOCS3-deleted neurons and to assess whether the regenerating axons could find the normal projection pathway and re-form synaptic connections with their central targets.
描述(由申请人提供):视神经损伤和再生失败是青光眼,遗传和创伤性神经病以及其他盲目疾病的主要特征。制定促进解剖学再生和功能重新连接受伤的视神经的策略一直是一个长期的挑战。通过在成年小鼠中使用眶内视神经损伤模型,我们发现RGC中SOCS3和PTEN/TSC1的条件缺失可促进明显的神经元存活和轴突再生。我们的进一步研究表明,MTOR是PTEN/TSC1缺失后轴突再生的关键介体,可能是通过控制受伤的神经元合成材料以实现轴突生长的能力。另一方面,我们的数据表明SOCS3缺失后的轴突再生取决于GP130信号传导。在该提案中,我们将解决以下问题:首先,SOC删除在促进神经元生存和轴突再生以及SOCS3是否是唯一的关键负面调节器中的效应子?其次,依赖SOCS3和PTEN/TSC1依赖性途径是否相互作用?第三,再生轴突是否能够找到其途径并介导功能恢复?我们预计这些实验将为理解视轴突再生的机制和神经修复治疗剂的发展提供重要的见解。
公共卫生相关性:视神经损伤和再生失败是青光眼,遗传和创伤性神经病以及其他盲目疾病的主要特征。制定促进解剖学再生和功能重新连接受伤的视神经的策略一直是一个长期的挑战。通过对floxed小鼠基因的AAV串联辅助敲除条件敲除,我们最近做出了一个令人兴奋的发现,即在成年视网膜神经节细胞(RGC)中删除SOCS3(细胞因子信号的抑制3),使稳健的长距离轴突再生能够在潜在的信号范围内揭示了潜在的信号量,从而揭示了潜在的信号量,并揭示了MENDERING量的量。神经元。这项拟议的研究的目标是两倍:确定允许SOCS3缺失神经元中轴突再生的潜在机制,并评估再生轴突是否可以找到正常的投影途径和与其中心靶标的重新形态突触连接。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZHIGANG HE其他文献
ZHIGANG HE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZHIGANG HE', 18)}}的其他基金
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10288673 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10662464 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10018669 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
Mechanism and Optimization of CBD-mediated analgesic effects
CBD介导的镇痛作用机制及优化
- 批准号:
10227071 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
CRSIPR 筛选视网膜神经节细胞存活和轴突再生的新型调节因子
- 批准号:
9920148 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
CBD介导的镇痛作用的机制和优化(多样性补充)
- 批准号:
10915759 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
CBD介导的镇痛作用的机制和优化(多样性补充)
- 批准号:
10714331 - 财政年份:2019
- 资助金额:
$ 43.5万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Activity-dependent endocannabinoid control in epilepsy
癫痫的活动依赖性内源性大麻素控制
- 批准号:
10639147 - 财政年份:2023
- 资助金额:
$ 43.5万 - 项目类别:
Cross-modal plasticity after the loss of vision at two early developmental ages in the posterior parietal cortex: Adult connections, cortical function and behavior.
后顶叶皮质两个早期发育年龄视力丧失后的跨模式可塑性:成人连接、皮质功能和行为。
- 批准号:
10751658 - 财政年份:2023
- 资助金额:
$ 43.5万 - 项目类别:
Microglial process convergence following brain injury
脑损伤后小胶质细胞过程收敛
- 批准号:
10657968 - 财政年份:2023
- 资助金额:
$ 43.5万 - 项目类别:
A Connectomic Analysis of a Developing Brain Undergoing Neurogenesis
正在经历神经发生的发育中大脑的连接组学分析
- 批准号:
10719296 - 财政年份:2023
- 资助金额:
$ 43.5万 - 项目类别:
The effect of aging on neurotransmitters and motor performance in a primate model
衰老对灵长类动物模型中神经递质和运动表现的影响
- 批准号:
10573386 - 财政年份:2023
- 资助金额:
$ 43.5万 - 项目类别: